Skip to content
Review

Probiotic-Derived Antimicrobial Proteins and Peptides: Molecular Mechanisms, Clinical Applications, and Future Therapeutic Perspectives.

Aug 2026 · Probiotics and Antimicrobial Proteins · 0 citations · 91 references
Medicine

TL;DR

This review aimed to synthesise the current evidence on PAP mechanisms, host-modulatory effects, and translational perspectives to present exciting avenues for clinical deployment of solutions in the early stages of development.

View source

Similar papers

Review Open access Aug 2026

Bacteriocin-Producing Probiotics as Precision Antimicrobial Therapeutics: From Lactic Acid Bacteria to Emerging and Engineered Next-Generation Platforms

The emergence of antimicrobial resistance (AMR) has created a need for new, targeted alternatives to conventional antibiotics. Bacteriocins and other targeted antimicrobial peptides (AMPs) are emerging therapeutic approaches that have attracted attention for their potent antimicrobial properties and potential for more...

Vishakha Tyagi, Ajay Kumar, N. Thapliyal et al. · 0 citations
Review Aug 2026

Antimicrobial peptides and enzymes: synergistic mechanisms and strategies for disrupting biofilm-associated infections.

Medical biofilms are a significant problem in chronic diseases like diabetic ulcers that do not heal, infections of medical devices and CF. The extracellular polymeric matrix is a barrier to antibiotic penetration. In search of an alternative, approaches based on antimicrobial peptides (AMPs) and enzymes have been deve...

S. Shukla, B. D. Iyer · 0 citations
Review Open access Sep 2026

Reframing Antimicrobial Peptides beyond Direct Antimicrobial Activity toward Host-Directed Functions and Disease-Specific Therapeutic Applications

Antimicrobial peptides (AMPs) have been extensively investigated as alternatives to conventional antibiotics to combat multidrug-resistant bacteria. This narrow antibiotic-replacement framework underestimates the biological and translational potential of AMPs. The present review reframes them as disease-context-depende...

Min-Ho Lee · 0 citations
Review Sep 2026

PLANT-DERIVED THERAPEUTICS AS A NOVEL STRATEGY TO COMBAT ANTIMICROBIAL RESISTANCE: CURRENT ADVANCES AND FUTURE PERSPECTIVE

Antimicrobial resistance (AMR) has emerged as one of the most critical global public health challenges of the 21st century, significantly compromising the effectiveness of conventional antibiotics and increasing morbidity, mortality, and healthcare costs worldwide. In this context, plant-derived therapeutics have gaine...

Deeksha Rathor, Pushpendra Kumar, Km. Neha et al. · 0 citations
Review Open access Sep 2026

Alternative Approaches to Antibiotics: Phage Therapy, Antimicrobial Peptides, and Phytotherapeutics

Antibiotic resistance has emerged as a critical threat to global health, food security, and economic stability due to the overuse of antibiotics in human medicine and livestock production. This review examines the mechanisms of antibiotic action and resistance, clinical and environmental consequences of resistance, and...

Haruna Abdullahi, Haliru Ahmad Kabiru, Habila Mamman Paul et al. · 0 citations
Review Open access Aug 2026

Defensins as natural antimicrobial peptide scaffolds against antimicrobial-resistant pathogens: mechanisms, resistance risks, and translational prospects

The growing threat of antimicrobial resistance has increased the need for anti-infective approaches beyond conventional single-target antibiotics. Defensins, a conserved family of cysteine-rich antimicrobial peptides, are promising candidates owing to their structural stability, membrane activity, target-specific mecha...

E. Abdallah, S. Al-Mijalli, N. al Hakawati et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.